ScripsAmerica Valuation
| SCRCQ Stock | USD 0.0001 0.00 0.00% |
ScripsAmerica seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of ScripsAmerica from inspecting the company fundamentals such as Current Valuation of 1.82 M, price to earning of (0.02) X, and Return On Asset of -0.53 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ScripsAmerica's price fluctuation is very steady at this time. Calculation of the real value of ScripsAmerica is based on 3 months time horizon. Increasing ScripsAmerica's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
ScripsAmerica's intrinsic value may or may not be the same as its current market price of 0.0001, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of ScripsAmerica's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ScripsAmerica's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ScripsAmerica helps investors to forecast how ScripsAmerica pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ScripsAmerica more accurately as focusing exclusively on ScripsAmerica's fundamentals will not take into account other important factors: ScripsAmerica Total Value Analysis
ScripsAmerica is at this time forecasted to have takeover price of 1.82 M with market capitalization of 1.41 K, debt of 1.07 M, and cash on hands of 160.85 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ScripsAmerica fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.82 M | 1.41 K | 1.07 M | 160.85 K |
ScripsAmerica Investor Information
The company recorded a loss per share of 0.04. ScripsAmerica had not issued any dividends in recent years. Based on the key measurements obtained from ScripsAmerica's financial statements, ScripsAmerica is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.ScripsAmerica Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ScripsAmerica has an asset utilization ratio of 546.68 percent. This connotes that the Company is making $5.47 for each dollar of assets. An increasing asset utilization means that ScripsAmerica is more efficient with each dollar of assets it utilizes for everyday operations.ScripsAmerica Profitability Analysis
The company reported the revenue of 30.85 M. Net Loss for the year was (4.73 M) with profit before overhead, payroll, taxes, and interest of 27.6 M.About ScripsAmerica Valuation
The pink sheet valuation mechanism determines ScripsAmerica's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of ScripsAmerica based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of ScripsAmerica. We calculate exposure to ScripsAmerica's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ScripsAmerica's related companies.ScripsAmerica, Inc. develops and sells non-sterile topical and transdermal pain creams. On February 8, 2017, the voluntary petition of ScripsAmerica, Inc. for reorganization under Chapter 11 was converted to Chapter 7. Scripsamerica operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 21 people.
8 Steps to conduct ScripsAmerica's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ScripsAmerica's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ScripsAmerica's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ScripsAmerica's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ScripsAmerica's revenue streams: Identify ScripsAmerica's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ScripsAmerica's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ScripsAmerica's growth potential: Evaluate ScripsAmerica's management, business model, and growth potential.
- Determine ScripsAmerica's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ScripsAmerica's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for ScripsAmerica Pink Sheet Analysis
When running ScripsAmerica's price analysis, check to measure ScripsAmerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ScripsAmerica is operating at the current time. Most of ScripsAmerica's value examination focuses on studying past and present price action to predict the probability of ScripsAmerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ScripsAmerica's price. Additionally, you may evaluate how the addition of ScripsAmerica to your portfolios can decrease your overall portfolio volatility.